Aveanna Healthcare reprices credit and revolver loans

Aveanna Healthcare Holdings Inc. announced that its subsidiary Aveanna Healthcare LLC has repriced its first lien credit and revolving credit facilities.

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Inc. announced that its subsidiary Aveanna Healthcare LLC has repriced its first lien credit and revolving credit facilities. The amendment refinances outstanding senior secured term loans with new 2026 Term Loans totaling $1,318,375,000 and renews a $250,000,000 senior secured revolving credit facility.

The 2026 Facilities reduce applicable interest rate margins by 0.50 percentage points. Both the term loans and revolver now bear interest at, at the borrower’s election, Term SOFR plus a 3.25% margin or a base rate plus a 2.25% margin. Margins may be reduced by an additional 0.25 percentage points if the borrower obtains a rating of at least B2 or B from specified credit rating agencies, while other key credit agreement terms remain largely unchanged.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

2026 Term Loans principal: $1,318,375,000 Revolving credit facility size: $250,000,000 Margin reduction: 0.50 percentage points +3 more

6 metrics

2026 Term Loans principal $1,318,375,000 Aggregate principal amount of new senior secured term loans

Revolving credit facility size $250,000,000 Principal amount of 2026 Refinancing Revolving Credit Facility

Margin reduction 0.50 percentage points Reduction to applicable interest rate margins under 2026 Facilities

SOFR-based margin 3.25% per annum Margin over Term SOFR on 2026 Term Loans and revolver

Base rate margin 2.25% per annum Margin over base rate on 2026 Term Loans and revolver

Potential extra margin cut 0.25 percentage points Additional reduction if borrower attains at least B2 or B rating

Key Terms

First Lien Credit Agreement, senior secured term loans, revolving credit facility, Term SOFR, +1 more

5 terms

First Lien Credit Agreement financial

"entered into the thirteenth amendment to its First Lien Credit Agreement, dated as of March 16, 2017"

A first lien credit agreement is a loan contract that gives the lender the top legal claim on a borrower's specific assets if the borrower defaults, like a mortgage that gets paid before others when a house is sold. It matters to investors because holders of first-lien debt are paid before other creditors and shareholders in a distress situation, which lowers their risk and can affect a company's borrowing costs, financial flexibility, and the value of other securities.

senior secured term loans financial

"the outstanding senior secured term loans under the Existing Credit Agreement were refinanced"

A senior secured term loan is a long‑term bank-style loan that a company must repay on a set schedule and that is backed by specific assets as collateral; “senior” means it gets paid before other debts if the borrower runs into trouble. For investors, these loans matter because their collateral and priority typically reduce the risk of loss compared with unsecured or junior debt, while the fixed repayment plan and contract terms influence a company’s cash flow, interest burden and financial flexibility—think of it like a mortgage on a business asset that lenders can claim first if payments stop.

revolving credit facility financial

"the existing $250,000,000 senior secured revolving credit facility was refinanced"

A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.

Term SOFR financial

"bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin"

Term SOFR is a benchmark interest rate that reflects the cost of borrowing money over a specific period, based on actual transactions in the financial markets. It is used by lenders and borrowers to set the interest rates on loans and financial contracts, helping to ensure rates are fair and transparent. For investors, understanding term SOFR helps gauge borrowing costs and the overall direction of interest rates in the economy.

Consolidated First Lien Net Leverage Ratio financial

"subject to adjustments based on Consolidated First Lien Net Leverage Ratio (as defined in the Credit Agreement)"

A consolidated first lien net leverage ratio measures how much high-priority secured debt a company (including its subsidiaries) carries after subtracting available cash, compared with its annual operating cash flow. Think of it like the remaining balance on the most important mortgage divided by a homeowner’s yearly income: a higher number means heavier debt burden and greater risk to lenders and investors, while a lower number signals more room to borrow and safer credit standing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aveanna Healthcare (AVAH) change in its debt facilities?

Aveanna Healthcare repriced its first lien term loans and revolving credit facility, refinancing them into new 2026 Facilities. The change primarily reduces interest rate margins while keeping other material credit agreement terms largely unchanged.

How large are Aveanna Healthcare’s new 2026 Term Loans?

The new 2026 Term Loans have an aggregate principal amount of $1,318,375,000. These loans refinance the company’s existing senior secured term loans under its first lien credit agreement without increasing the disclosed principal balance.

What is the size of Aveanna Healthcare’s revolving credit facility?

Aveanna Healthcare refinanced its existing $250,000,000 senior secured revolving credit facility with a new $250,000,000 2026 Refinancing Revolving Credit Facility. This facility provides ongoing borrowing capacity under the amended first lien credit agreement.

How much did Aveanna Healthcare reduce its interest rate margins?

The amendment provides a 0.50 percentage point reduction to applicable interest rate margins on the term loans and revolver. This directly lowers interest costs on the company’s senior secured debt under the amended facilities.

Can Aveanna Healthcare’s loan margins be reduced further under the amendment?

Yes. The amendment allows an additional 0.25 percentage point margin reduction if the borrower obtains a credit rating of at least B2 or B from certain rating agencies, further lowering borrowing costs if that condition is met.

What interest rate options apply to Aveanna’s 2026 Facilities?

Both the 2026 Term Loans and revolving credit facility bear interest at, at the borrower’s election, Term SOFR plus a 3.25% margin or a base rate plus a 2.25% margin, subject to the potential rating-based margin reduction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 08:00 AM EDT Learn about SEC filing dates

0001832332false00018323322026-05-262026-05-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 26, 2026

Aveanna Healthcare Holdings Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-40362	81-4717209
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
400 Interstate North Parkway SE
Atlanta, Georgia				30339
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 770 441-1580

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AVAH		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On May 26, 2026, Aveanna Healthcare LLC, a Delaware limited liability company (the "Borrower"), a wholly owned subsidiary of Aveanna Healthcare Holdings, Inc. (the "Company"), entered into the thirteenth amendment (the "Amendment") to its First Lien Credit Agreement, dated as of March 16, 2017 (as further amended, supplemented, or otherwise modified from time to time as of the date hereof, the "Existing Credit Agreement"), among the Borrower, Aveanna Healthcare Intermediate Holdings LLC, as Holdings, the subsidiaries of the Borrower party thereto, the lenders party thereto, Barclays Bank PLC as administrative agent and collateral agent, and other agents party thereto (the Existing Credit Agreement, as amended by the Amendment, the "Credit Agreement").

The Amendment constitutes a repricing of the facilities under the Existing Credit Agreement resulting in a 0.50% reduction to applicable interest rate margins. Pursuant to the Amendment, the outstanding senior secured term loans under the Existing Credit Agreement were refinanced with new senior secured term loans in an aggregate principal amount of $1,318,375,000 (the “2026 Term Loans”) and the existing $250,000,000 senior secured revolving credit facility was refinanced with a new $250,000,000 senior secured revolving credit facility (the “2026 Refinancing Revolving Credit Facility” and, together with the 2026 Term Loans, the “2026 Facilities”). The 2026 Term Loans bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin equal to 3.25% per annum or a base rate plus an applicable margin equal to 2.25% per annum. Loans under the 2026 Refinancing Revolving Credit Facility bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin equal to 3.25% per annum or a base rate plus an applicable margin equal to 2.25% per annum, subject to adjustments based on Consolidated First Lien Net Leverage Ratio (as defined in the Credit Agreement) as of the last day of the preceding fiscal quarter.

The Amendment further provides for a reduction of 0.25% to the applicable margins described above upon the Borrower obtaining a rating of at least B2 or B from certain credit rating agencies.

Other terms and conditions in the Existing Credit Agreement were not materially amended as part of the Amendment.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, including exhibits thereto, which the Company intends to attach as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 27, 2026.

On May 28, 2026, the Company issued a press release announcing the Amendment. The full text of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press Release dated May 28, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			AVEANNA HEALTHCARE HOLDINGS INC.
Date:	May 28, 2026	By:	/s/ Matthew Buckhalter
			Matthew Buckhalter Chief Financial Officer (Principal Financial Officer)

Exhibit 99.1

Aveanna HEALTHCARE ANNOUNCES SUCCESSFUL DEBT REPRICING

Atlanta, Georgia (May 28, 2026) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (Nasdaq: AVAH), a leading, diversified home care platform focusing on providing care to medically complex, high-cost patient populations, today announced the repricing of its first lien credit facility and revolving credit facility. The repriced credit facilities provide for a 50 basis point reduction to applicable interest rate margins, as well as an additional reduction of 25 basis points to the applicable margins upon the Borrower obtaining a rating of at least B2 or B from certain credit rating agencies.

“We are encouraged by our financing partners' confidence in our commitment to operational excellence”, said Matt Buckhalter, Chief Financial Officer. “We believe today’s repricing of our credit facility supports our ongoing efforts to strengthen the balance sheet and provides additional flexibility as we continue executing Aveanna’s strategic growth initiatives.”

About Aveanna Healthcare

Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 39 states providing a broad range of pediatric and adult healthcare services, primarily focused on care in the home, including nursing, hospice, rehabilitation, occupational nursing in schools, therapy, and day treatment center services for medically complex and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.

Forward-Looking Statements

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements (other than statements of historical facts) in this press release regarding our repricing of our credit facility, prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward-looking statements. Forward-looking statements generally can be identified by the use of terminology such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “should,” “would,” “predict,” “project,” “potential,” “continue,” “could,” “design,” “guidance,” or the negatives of these terms or variations of them or similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, the risks and uncertainties set forth under the heading “Risk Factors” in Aveanna’s Annual Report on Form 10-K for its 2025 fiscal year filed with the Securities and Exchange Commission on March 19, 2026, which is available at www.sec.gov. Accordingly, forward-looking statements included in this press release do not purport to be predictions of future events or circumstances, and actual results may differ materially from those expressed by forward-looking statements. All forward-looking statements speak only as of the date made, and Aveanna undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Exhibit 99.1

Investor Contact

Matt Buckhalter

Chief Financial Officer

ir@aveanna.com

Filing Exhibits & Attachments

2 documents

Press Releases

• EX-99.1 EX-99.1 10.2 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 23.3 KB